Barclays PLC acquired a new position in shares of HEXO Corp. (NASDAQ:HEXO) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 811,346 shares of the company’s stock, valued at approximately $3,213,000. Barclays PLC owned about 0.32% of HEXO at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently modified their holdings of the business. Penserra Capital Management LLC bought a new stake in HEXO during the third quarter worth approximately $148,000. USA Mutuals Advisors Inc. bought a new stake in HEXO during the third quarter worth approximately $592,000. Signition LP increased its stake in HEXO by 56.1% during the third quarter. Signition LP now owns 49,000 shares of the company’s stock worth $194,000 after acquiring an additional 17,600 shares during the last quarter. Tower Research Capital LLC TRC increased its stake in HEXO by 90.9% during the third quarter. Tower Research Capital LLC TRC now owns 36,640 shares of the company’s stock worth $144,000 after acquiring an additional 17,446 shares during the last quarter. Finally, Chicago Partners Investment Group LLC bought a new stake in HEXO during the third quarter worth approximately $27,000.
Several equities research analysts have weighed in on HEXO shares. Canaccord Genuity cut HEXO from a “buy” rating to a “hold” rating in a research note on Wednesday, October 30th. MKM Partners assumed coverage on HEXO in a research note on Friday, September 20th. They set a “buy” rating and a $12.00 target price on the stock. Beacon Securities cut HEXO from a “buy” rating to a “hold” rating in a research note on Thursday, October 10th. Seaport Global Securities cut HEXO from a “buy” rating to a “neutral” rating in a research note on Monday, October 14th. Finally, Jefferies Financial Group raised HEXO from an “underperform” rating to a “hold” rating in a research note on Friday, October 11th. Five research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $6.52.
HEXO (NASDAQ:HEXO) last released its earnings results on Monday, October 28th. The company reported ($0.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.06). The firm had revenue of $11.79 million during the quarter, compared to analysts’ expectations of $11.31 million.
HEXO Corp., through its subsidiary, HEXO Operations Inc, produces, markets, and sells cannabis in Canada. The company offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. It provides its products under the HEXO and Hydropothecary brand names.
Featured Article: How to Invest in Stocks with Increasing Dividends
Want to see what other hedge funds are holding HEXO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HEXO Corp. (NASDAQ:HEXO).
Receive News & Ratings for HEXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HEXO and related companies with MarketBeat.com's FREE daily email newsletter.